Physician profile
Andrew B Roberts
NPI 1578635371
$913.31
in general payments reported to CMS, 2019-2025
17 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $239 · 2021: $131 · 2022: $94.16 · 2023: $17.62 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $136.64 | 2019-2022 | |
| Medtronic USA, INC. | $126.04 | 2020 | |
| Stryker Corporation | $116.08 | 2020-2025 | Ivas |
| Nevro Corp. | $64.46 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $53.63 | 2019 | |
| Biodelivery Sciences International, INC. | $53.56 | 2019-2020 | |
| Medtronic, INC. | $52.70 | 2021 | |
| Allergan, INC. | $45.36 | 2019 | |
| Spineology INC. | $44.49 | 2021 | |
| Scilex Pharmaceuticals INC. | $41.66 | 2019 | |
| Si-Bone, INC. | $37.40 | 2023-2025 | |
| Surgalign Spine Technologies, INC. | $33.40 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $31.76 | 2025 | |
| Cerapedics INC. | $22.92 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Abbott Laboratories | $21.71 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $19.61 | 2022 | |
| Astellas Pharma US INC | $11.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.